Related Experiment Video
Updated: Aug 19, 2026
Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
Xiaofeng Li1, Yazhou Zhang, Heeseog Kang
1Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, 06030, USA.
Abstract:
The loss of the SOST gene product sclerostin leads to sclerosteosis characterized by high bone mass. In this report, we found that sclerostin could antagonize canonical Wnt signaling in human embryonic kidney A293T cells and mouse osteoblastic MC3T3 cells. This sclerostin-mediated antagonism could be reversed by overexpression of Wnt co-receptor low density lipoprotein receptor-related protein (LRP) 5. In addition, we found that sclerostin bound to LRP5 as well as LRP6 and identified the first two YWTD-EGF repeat domains of LRP5 as being responsible for the binding. Although these two repeat domains are required for transduction of canonical Wnt signals, canonical Wnt did not appear to compete with sclerostin for binding to LRP5. Examination of the expression of sclerostin and Wnt7b, an autocrine canonical Wnt, during primary calvarial osteoblast differentiation revealed that sclerostin is expressed at late stages of osteoblast differentiation coinciding with the expression of osteogenic marker osteocalcin and trailing after the expression of Wnt7b. Given the plethora of evidence indicating that canonical Wnt signaling stimulates osteogenesis, we believe that the high bone mass phenotype associated with the loss of sclerostin may be attributed, at least in part, to an increase in canonical Wnt signaling resulting from the reduction in sclerostin-mediated Wnt antagonism.
Insights
Sclerostin antagonizes Wnt signaling, a key pathway in bone formation. Loss of sclerostin increases Wnt signaling, potentially explaining the high bone mass seen in sclerosteosis.
Area of Science:
- Molecular biology
- Cell biology
- Bone biology
Background:
- Sclerostin, encoded by the SOST gene, is a known inhibitor of bone formation.
- Sclerosteosis, a condition of high bone mass, results from the loss of sclerostin.
- Canonical Wnt signaling is crucial for osteogenesis.
Purpose of the Study:
- To investigate the mechanism by which sclerostin antagonizes canonical Wnt signaling.
- To identify the binding interaction between sclerostin and its co-receptors.
- To explore the role of sclerostin in osteoblast differentiation.
Main Methods:
- Cell-based assays using human embryonic kidney A293T and mouse osteoblastic MC3T3 cells.
- Overexpression studies of Wnt co-receptor low density lipoprotein receptor-related protein (LRP) 5.
- Binding assays to determine sclerostin-LRP interactions.
- Analysis of gene expression during primary calvarial osteoblast differentiation.
Main Results:
- Sclerostin antagonizes canonical Wnt signaling in vitro.
- Overexpression of LRP5 reverses sclerostin-mediated Wnt antagonism.
- Sclerostin binds to LRP5 and LRP6, with the first two YWTD-EGF repeat domains of LRP5 mediating the interaction.
- Sclerostin expression is upregulated at later stages of osteoblast differentiation, following Wnt7b expression.
Conclusions:
- Sclerostin inhibits canonical Wnt signaling by binding to LRP5/6.
- The high bone mass in sclerosteosis may be due to reduced Wnt antagonism from decreased sclerostin levels.
- Understanding sclerostin's role in Wnt signaling provides insights into bone metabolism and potential therapeutic targets.
More Related Videos
Related Concept Videos
01:41Non-Canonical Wnt Signaling Pathways
01:41Non-Canonical Wnt Signaling Pathways
02:54Canonical Wnt Signaling Pathway
02:54Canonical Wnt Signaling Pathway
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal